Health officials are launching a fresh study into side effects as data shows number of reported cases of pancreatitis, some ...

The drug works to suppress appetite and has been embraced by celebrities. It's approved by MedSafe but not funded by Pharmac, so users will have to pay. The drug is injected weekly and alongside ...

New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes ...

Holli Bradish-Lane unveils The GLP-1 Exit Plan, a pioneering book designed to guide individuals safely off weight-loss ...

Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with pancreatitis and told to stop taking the weight-loss jab ...

To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.